ehmt2

EHMT2-IN-1 is a potent EHMT inhibitor used in blood disorder and cancer research, with IC50 values all below 100 nM for EHMT1 peptide, EHMT2 peptide, and cellular EHMT2.

EHMT2-IN-2 Used in the research of blood disease or cancer. EHMT2-IN-2 is a potent EHMT inhibitor, with IC50s of all <100 nM for EHMT1 peptide, EHMT2 peptide and cellular EHMT2.

BRD4770, a histone methyltransferase G9a inhibitor, induces cell senescence.

BRD9539 is an inhibitor of euchromatin histone methyltransferase 2 (EHMT2), also known as G9a, with an IC50 value of 6.3 μM

MS152 is an orally active EHMT2/G9a inhibitor. It can reactivate the maternally silenced PWS genes in brain and liver tissues of a Prader-Willi Syndrome (PWS) mouse model.

5WKS also known as ZINC97756584 is a biochemical. It is a G9a protein inhibitor.G9A/EHMT2 is a nuclear histone lysine methyltransferase that catalyzes H3K9me2, a reversible modification commonly associated with transcriptional gene silencing.5WKS can be used in the study of autoimmune diseases or tumors.

CSV0C018875 is a quinoline-based EHMT2/G9a inhibitor that exhibits lower cytotoxicity compared to BIX-01294 [1].

CSV0C018875 Hydrochloride is a novel G9a (EHMT2) inhibitor, binding tightly inside the active site cavity of G9a, inhibiting the activity of G9a in both enzyme and cell based assays with much lesser toxicity than BIX-0129.